EXPLAINED: Vinia - The Real Truth

BioHarvest Sciences Q1 Earnings Call Highlights

BioHarvest Sciences (NASDAQ:BHST) reported higher first-quarter revenue and reiterated its 2026 outlook as management detailed a broader reorganization around two business lines: its direct-to-consumer VINIA products business and its contract development and manufacturing organization, or CDMO, plat

MarketBeat · May 14

BioHarvest Sciences Q2 2022, Record VINIA Sales, Successful R&D Of Cannabis Biomass Production In Bioreactors

BioHarvest Sciences Inc. (OTCPK:CNVCF) (CSE:BHSC) (FSE:8MV) revealed Q2 2022 sales orders of its flagship VINIA product reached a record high of $947,000, representing 99% growth compared to the same quarter of last year and 24% growth compared to Q1 2022.

Benzinga · Jul 5, 2022

BioHarvest Sciences Announces A Private Placement Of Up To $5M Of Convertible Notes

BioHarvest Sciences Inc. (OTCPK: CNVCF) (CSE: BHSC) (FSE:8MV) announced a financing plan based on a private placement of up to $5 million. The funds raised will allow the company to accelerate the growth plan for its polyphenols/antioxidants and cannabis verticals.

Benzinga · Apr 7, 2022